Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0008031 (
chest pain
)
17,248
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The antiischemic effects of the beta-1 selective beta-blocker metoprolol were studied in 9 hospitalized patients with rest angina in a double-blind, placebo-controlled, cross-over study. After 3 days of placebo treatment, the patients were randomized to metoprolol 100 mg or placebo bid for 2 days, followed by 2 days on the alternative treatment. During the last 24 hours of each period, Holter monitoring was performed. The patients marked angina attacks and
NTG
consumption on diary cards. Metoprolol significantly reduced the mean number of ST-changes (run-in: 5.7 +/- 0.6; metoprolol: 2.2 +/- 0.9; p = 0.013), the mean maximal ST-change during the attacks (run-in: 3.0 +/- 1.2 mm; metoprolol: 1.5 +/- 0.4 mm; p = 0.015), the mean duration of the ST-changes (run-in: 7.0 +/- 0.6 min; metoprolol: 3.2 +/- 1.0 min; p = 0.015), and the total ischemic time/24 (run-in: 41.1 +/- 7.6; metoprolol: 13.1 +/- 7.2 min; p = 0.008). None of these parameters was modified by placebo. However, the difference between metoprolol and the randomized placebo did not reach statistical significance. Metoprolol also reduced the number of
chest pain
attacks (p = 0.008), the duration of the attacks (p = 0.051), the severity score of the attacks (p = 0.008), and
NTG
consumption (p = 0.018) with respect to the run-in period. Six of the patients showed marked improvement on metoprolol while 3 showed only slight improvement or no change. No patients experienced worsening of angina or ST-changes.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Cardioselective beta-blockade with metoprolol in rest angina: a randomized, double-blind, placebo-controlled, cross-over trial. 266 58
The dose of intravenously administered nitroglycerin (IV
NTG
) used to control ischemic
chest pain
usually is limited by hypotension from decreased preload. Herein we describe 2 patients who tolerated IV
NTG
without hemodynamic compromise but in whom severe impairment of blood oxygen content developed from methemoglobinemia noted during coronary bypass surgery. Methemoglobinemia must be suspected if chocolate-brown blood is encountered despite a normal arterial oxygen tension and calculated oxygen saturation. Before a methemoglobin level is available, the extent of hypoxemia can be determined by an oximetric oxygen saturation and therapy begun with intravenous administration of methylene blue. These case reports focus attention on the potential deleterious effects of undetected hypoxemia from methemoglobinemia in patients being stabilized with high-dose IV
NTG
for urgent cardiac surgery.
...
PMID:Methemoglobinemia from intravenous nitroglycerin: a word of caution. 310 57
The diagnosis of silent ischaemic heart disease may be important in men as well as in women. However, diagnosing women by exercise ECG is limited due to the higher rate of false positive results. For improving diagnostic validity the following investigations were done. In 310 women, aged 41-63 years (mean age 47 years', revealing 'pathological' exercise ECG, further testing was performed using nitroglycerin (
NTG
0.8 mg). As a reference method, pulmonary artery (PA) pressure measurement was used. As a result of
NTG
testing, two groups could be separated: (a) those in whom ST segment depression remained constant (N = 217,
NTG
negatives = 70%). Since the end-diastolic PA pressure was found normal, these results were interpreted to be false-positive. (b)
NTG
effected a reduction or normalization of exercise induced ST segment changes (N = 93,
NTG
positives = 30%). There was a correspondence with exercise inducible end-diastolic PA pressure decrease. Consequently, true positives were assumed. Analysis of angina pectoris history indicated typical
chest pain
in 2% of
NTG
negatives only, but in 16% of
NTG
positives. In agreement with this during exercise, angina was reported by
NTG
negatives in 3% of cases and by
NTG
positive in 17%. The rest of this group (83%) is considered having exercise induceable silent myocardial ischaemia. When checking-up after five years, exercised-induced angina could be found in 4% of
NTG
negatives again, but in 36% of
NTG
positives. It was concluded that exercise testing by additionally using nitroglycerin is a rather important approach for diagnosing myocardial ischaemia in women.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Diagnosis of silent myocardial ischemia in women. 314 36
The aim of this study was to evaluate the duration of the hemodynamic effects of a new slow release preparation of isosorbide dinitrate and to compare its action with placebo and a slow release nitroglycerin preparation whose hemodynamic efficacity has already been demonstrated. The study was undertaken in 30 patients admitted to the intensive care unit during the acute phase of myocardial infarction complicated by left ventricular failure less than 12 hours after the onset of the
chest pain
. The patient population was uniform: 24 males, 6 females, mean age 61 years. Fifteen patients had anterior infarcts and 15 posterior infarcts. The drugs were administered double blind in a randomised fashion to 3 groups of 10 patients, the initial clinical and hemodynamic characteristics of which were comparable: 10 patients received placebo (placebo group); 10 patients received slow release nitroglycerin in a 7,5 mg gelule (
NTG
group) and 10 patients received 40 mg slow release isosorbide dinitrate (ISDN group). The following parameters were compared: heart rate, right atrial pressure, pulmonary artery and capillary pressures, systemic arterial pressure, cardiac index and systemic and pulmonary arterial resistances. These parameters were measured before therapy, half an hour, one hour and every two hours up to the 8th hour after drug administration. All patients were in moderate left ventricular failure with an initial mean capillary pressure of 18 mmHg +/- 1,3 mmHg. In the placebo group, none of the parameters studied changed significantly during the study. Pulmonary artery pressure fell significantly by 11 p. cent in the
NTG
group and 7,5 p. cent in the ISDN group. Mean pulmonary capillary pressure fell progressively in both treatment groups; the change was significant compared to the placebo group from the first hour for the ISDN group, and from the second hour for the
NTG
group. The fall remained significant at the 8th hour for the ISDN group but not in the
NTG
group. Cardiac index, systemic blood pressure, systemic and pulmonary arterial resistances did not change significantly. The cardiac index remained stable in the 30 patients, but with a number of individual variations depending on initial mean pulmonary capillary pressure and the importance of its fall after nitrate administration. The authors conclude that the hemodynamic effects of slow release
NTG
and ISDN in the acute phase of myocardial infarction complicated by moderate left ventricular failure are comparable. Pulmonary capillary pressure was the hemodynamic parameter which underwent the greatest variation in the two treatment groups. Its fall was more prolonged in the ISDN than in the
NTG
group.
...
PMID:[8-hour hemodynamic study of 2 sustained-release nitrate derivatives. Comparative double-blind study against placebo]. 640 29
We obtained myocardial imaging with Tl during pharmacologic interventions. Dipyridamole-loading myocardial imaging was performed in 38 patients with CAD. The diagnostic accuracy of this method was 66%. The combination of dipyridamole-loading and exercise stress myocardial imaging increased the diagnostic sensitivity of CAD from 71% (exercise stress imaging only) to 87%. In addition, dipyridamole-loading myocardial imaging was useful for the diagnosis of CAD in patients who could not perform exercise stress test.
Chest pain
and ST-segment depression were induced less often during dipyridamole administration than exercise stress test. Animal experiments showed that dipyridamole caused abnormalities in myocardial blood flow and myocardial Tl uptake distal to the critical coronary stenosis. And dipyridamole increased myocardial blood flow by 142% and myocardial Tl concentration by 62% in the normally perfused myocardial segments. Ergonovine-loading myocardial imaging was performed in 8 patients with resting angina and without significant coronary stenosis. And in all of them, ergonovine induced cold-spots on myocardial imaging with or without
chest pain
and ST-segment shift. Ergonovine-loading myocardial imaging was useful for the diagnosis of angina induced by coronary artery spasm. The combination of initial and delayed resting myocardial imaging was useful to differentiate the underperfused but viable myocardium from the scar. And by comparing with radionuclide angiography obtained before and after
NTG
administration,
NTG
-loading myocardial imaging and ECG findings in 20 patients with CAD, we demonstrated that the transient defective myocardial segments were underperfused but viable.
...
PMID:Noninvasive detection of coronary artery disease by myocardial imaging with thallium-201--the significance of pharmacologic interventions. 677 29
A prospective case series was conducted to demonstrate the safety and efficacy of intravenous nitroglycerin (i.v.
NTG
) boluses in the treatment of ischemic
chest pain
(CP) in the emergency department (ED). Patients with CP symptomatic after sublingual nitroglycerin (SL
NTG
) therapy with a systolic blood pressure (SBP) greater than 95 mmHg were included. Patients were treated with i.v.
NTG
boluses of 0.05 mg to 0.4 mg during a 1- to 2-minute period per a protocol based on the patient's prebolus SBP. This was followed by a maintenance infusion. Additional
NTG
boluses were repeated every 5 minutes as needed. The end point of treatment was the resolution of chest discomfort, thrombolysis, or a SBP less than 95 mmHg. There were 16 cases of CP. All 16 patients treated, ie, 5 with acute myocardial infarction and 11 with unstable angina showed significant decrease in chest discomfort after 1 to 2 boluses. Two of five with acute myocardial infarction and 9 of 11 patients with unstable angina had complete relief of
chest pain
after 1 to 4 boluses. There were no episodes of hypotension (SBP < 90 mmHg) in any of the 16 cases. The judicious use of i.v.
NTG
boluses administered during a 1- to 2-minute period, in the ED, appears safe and efficacious in patients with CP unresponsive to SL
NTG
therapy.
...
PMID:Bolus i.v. nitroglycerin treatment of ischemic chest pain in the ED. 766 71
Nitroglycerin (glyceryl trinitrate, CAS 55-63-0,
NTG
) administered with an oral spray may be more effective in relieving anginal pain than sublingual tablets especially when the patient's mouth is dry. In this study, the effect of a
NTG
oral spray (Myocor Spray) on exercise-induced angina was compared with that of a sublingual tablet in relation to the oral dryness. In 17 patients with effort angina, graded bicycle exercise was performed twice at an interval of one week. Exercise was discontinued upon the onset of moderate anginal pain. Immediately after exercise, the oral dryness was evaluated by touching the tip of the tongue with a blotting paper for a moment. Then, 0.3 mg of
NTG
was administered by either a squirt of spray or a sublingual tablet in a randomized crossover fashion. Exercise results were reproducible between two exercise tests. According to the extent of the wet area of the blotting paper, the subjects were divided into two groups. In 7 patients of the wet group, the remission times of
chest pain
and ST segment depression were not significantly different by the formulation of
NTG
. In 10 patients of the dry group, however, both
chest pain
and ST depression more rapidly recovered with use of the oral spray (p < 0.05 and p < 0.05, respectively). These results strongly suggest that the
NTG
oral spray is superior to the sublingual tablet in relieving anginal attacks, when the oral wetness is decreased.
...
PMID:Studies on the response of nitroglycerin oral spray compared with sublingual tablets for angina pectoris patients with dry mouth. A multicenter trial. 907 31
The atherosclerotic process is an ongoing dynamic and progressive state arising from endothelial dysfunction and inflammation. Although suffering from an acute coronary artery disease, patients with Type II diabetes have a poor outcome compared with non-diabetic patients, which may only partly be explained by traditional risk factors. Our purpose was to compare non-traditional risk factors, such as endothelial function, C-reactive protein (CRP) and adiponectin, in Type II diabetic and non-diabetic patients following AMI (acute myocardial infarction). Twenty Type II diabetic patients were compared with 25 non-diabetic patients at baseline (1-3 days from the onset of
chest pain
) and at 60 days follow-up after an AMI. Using high-resolution ultrasound, brachial artery responses to FMD (flow-mediated vasodilatation; endothelium-dependent vasodilatation) and
NTG
(nitroglycerine-induced vasodilatation; endothelium-independent vasodilatation) were measured. Plasma levels of CRP and adiponectin were measured by ELISA. At baseline, FMD (1.9 compared with 3.2%; P=0.22) and CRP levels (6.95 compared with. 5.51 mg/l; P=0.40) did not differ between Type II diabetic and non-diabetic patients, whereas adiponectin levels were lower in Type II diabetic patients (2.8 compared with 5.0 ng/ml; P<0.05). At 60 days follow-up, there were significant differences in FMD (1.5 compared with 4.1%; P<0.02), CRP (4.23 compared with 1.46 mg/ml; P<0.01) and adiponectin (3.3 compared with 5.3 ng/ml; P<0.05) levels between Type II diabetic and non-diabetic patients. In contrast,
NTG
responses improved in both groups between baseline and follow-up (Type II diabetic patients, 9.7 compared with 13.2% respectively, P<0.05; non-diabetic patients, 7.9 compared with 12.4% respectively, P<0.01). These results show a persistent endothelium-dependent dysfunction and inflammatory activity in patients with Type II diabetes, but not in non-diabetic patients, after AMI. These findings may, in part explain, the poor outcome in coronary artery disease seen in Type II diabetes.
...
PMID:Persistent endothelial dysfunction is related to elevated C-reactive protein (CRP) levels in Type II diabetic patients after acute myocardial infarction. 1550 6